p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation

References

• Richmond CA, Breault DT. Regulation of gene expression in the intestinal epithelium. Prog Mol Biol Transl Sci 2010; 96:207 - 29; http://dx.doi.org/10.1016/B978-0-12-381280-3.00009-9; PMID: 21075346
   PubMed Web of Science ®Google Scholar
• Radtke F, Clevers H, Riccio O. From gut homeostasis to cancer. Curr Mol Med 2006; 6:275 - 89; http://dx.doi.org/10.2174/156652406776894527; PMID: 16712475
   PubMed Web of Science ®Google Scholar
• Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005; 307:1904 - 9; http://dx.doi.org/10.1126/science.1104815; PMID: 15790842
   PubMed Web of Science ®Google Scholar
• Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 2004; 20:695 - 723; http://dx.doi.org/10.1146/annurev.cellbio.20.010403.092805; PMID: 15473857
   PubMed Web of Science ®Google Scholar
• Tetreault MP, Wang ML, Yang Y, Travis J, Yu QC, Klein-Szanto AJ, et al. Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology 2010; 139:2124 - 34, e9; PMID: 20816834
   PubMed Web of Science ®Google Scholar
• Tetreault MP, Yang Y, Travis J, Yu QC, Klein-Szanto A, Tobias JW, et al. Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. Gastroenterology 2010; 139:171 - 81, e9; PMID: 20347813
   PubMed Web of Science ®Google Scholar
• Segre JA, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 1999; 22:356 - 60; http://dx.doi.org/10.1038/11926; PMID: 10431239
   PubMed Web of Science ®Google Scholar
• Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 2005; 24:1491 - 500; http://dx.doi.org/10.1038/sj.onc.1208307; PMID: 15674344
   PubMed Web of Science ®Google Scholar
• Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006; 6:11 - 23; http://dx.doi.org/10.1038/nrc1780; PMID: 16372018
   PubMed Web of Science ®Google Scholar
• Vooijs M, Liu Z, Kopan R. Notch: architect, landscaper, and guardian of the intestine. Gastroenterology 2011; 141:448 - 59; http://dx.doi.org/10.1053/j.gastro.2011.06.003; PMID: 21689653
   PubMed Web of Science ®Google Scholar
• Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene 2008; 27:5124 - 31; http://dx.doi.org/10.1038/onc.2008.226; PMID: 18758481
   PubMed Web of Science ®Google Scholar
• Dotto GP. Notch tumor suppressor function. Oncogene 2008; 27:5115 - 23; http://dx.doi.org/10.1038/onc.2008.225; PMID: 18758480
   PubMed Web of Science ®Google Scholar
• Yang Y, Goldstein BG, Nakagawa H, Katz JP. Krüppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells. FASEB J 2007; 21:543 - 50; http://dx.doi.org/10.1096/fj.06-6694com; PMID: 17158781
   PubMed Web of Science ®Google Scholar
• Goldstein BG, Chao HH, Yang Y, Yermolina YA, Tobias JW, Katz JP. Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1784 - 92; http://dx.doi.org/10.1152/ajpgi.00541.2006; PMID: 17395897
   PubMedGoogle Scholar
• McConnell BB, Ghaleb AM, Nandan MO, Yang VW. The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007; 29:549 - 57; http://dx.doi.org/10.1002/bies.20581; PMID: 17508399
   PubMed Web of Science ®Google Scholar
• Nandan MO, Chanchevalap S, Dalton WB, Yang VW. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation. FEBS Lett 2005; 579:4757 - 62; http://dx.doi.org/10.1016/j.febslet.2005.07.053; PMID: 16102754
   PubMed Web of Science ®Google Scholar
• Nandan MO, Yoon HS, Zhao W, Ouko LA, Chanchevalap S, Yang VW. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 2004; 23:3404 - 13; http://dx.doi.org/10.1038/sj.onc.1207397; PMID: 15077182
   PubMed Web of Science ®Google Scholar
• Yang Y, Goldstein BG, Chao HH, Katz JP. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 2005; 4:1216 - 21; http://dx.doi.org/10.4161/cbt.4.11.2090; PMID: 16357509
   PubMed Web of Science ®Google Scholar
• Bateman NW, Tan D, Pestell RG, Black JD, Black AR. Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 2004; 279:12093 - 101; http://dx.doi.org/10.1074/jbc.M311532200; PMID: 14726538
   PubMed Web of Science ®Google Scholar
• Yang Y, Nakagawa H, Tetreault MP, Billig J, Victor N, Goyal A, et al. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res 2011; 71:6475 - 84; http://dx.doi.org/10.1158/0008-5472.CAN-11-1702; PMID: 21868761
   PubMed Web of Science ®Google Scholar
• Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994; 54:4342 - 6; PMID: 8044781
   PubMed Web of Science ®Google Scholar
• Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87:9958 - 61; http://dx.doi.org/10.1073/pnas.87.24.9958; PMID: 2263646
   PubMed Web of Science ®Google Scholar
• Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, et al. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 2003; 1:729 - 38; PMID: 12939398
   PubMed Web of Science ®Google Scholar
• Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106:761 - 71; http://dx.doi.org/10.1083/jcb.106.3.761; PMID: 2450098
   PubMed Web of Science ®Google Scholar
• Barnas C, Martel-Planche G, Furukawa Y, Hollstein M, Montesano R, Hainaut P. Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer 1997; 71:79 - 87; http://dx.doi.org/10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4; PMID: 9096669
   PubMed Web of Science ®Google Scholar
• Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007; 26:2157 - 65; http://dx.doi.org/10.1038/sj.onc.1210302; PMID: 17401424
   PubMed Web of Science ®Google Scholar
• Soussi T, Asselain B, Hamroun D, Kato S, Ishioka C, Claustres M, et al. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 2006; 12:62 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-05-0413; PMID: 16397025
   PubMed Web of Science ®Google Scholar
• Dulić V, Stein GH, Far DF, Reed SI. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 1998; 18:546 - 57; PMID: 9418901
   PubMed Web of Science ®Google Scholar
• Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497 - 501; http://dx.doi.org/10.1126/science.282.5393.1497; PMID: 9822382
   PubMed Web of Science ®Google Scholar
• Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55:5187 - 90; PMID: 7585571
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817 - 25; http://dx.doi.org/10.1016/0092-8674(93)90500-P; PMID: 8242752
   PubMed Web of Science ®Google Scholar
• Wang B, Xiao Z, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci USA 2009; 106:14373 - 8; http://dx.doi.org/10.1073/pnas.0903284106; PMID: 19597154
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55:2910 - 9; PMID: 7796420
   PubMed Web of Science ®Google Scholar
• Guo P, Dong XY, Zhang X, Zhao KW, Sun X, Li Q, et al. Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J Biol Chem 2009; 284:6071 - 8; http://dx.doi.org/10.1074/jbc.M806270200; PMID: 19056724
   PubMed Web of Science ®Google Scholar
• Dupont S, Zacchigna L, Adorno M, Soligo S, Volpin D, Piccolo S, et al. Convergence of p53 and TGF-beta signaling networks. Cancer Lett 2004; 213:129 - 38; http://dx.doi.org/10.1016/j.canlet.2004.06.008; PMID: 15327827
   PubMed Web of Science ®Google Scholar
• Lane D, Levine A. p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2010; 2:a000893; http://dx.doi.org/10.1101/cshperspect.a000893; PMID: 20463001
   PubMed Web of Science ®Google Scholar
• Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402 - 12; http://dx.doi.org/10.1038/nrm2395; PMID: 18431400
   PubMed Web of Science ®Google Scholar
• Hill R, Madureira PA, Waisman DM, Lee PW. DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget 2011; 2:1094 - 108; PMID: 22190353
   PubMed Web of Science ®Google Scholar
• Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2010; 2:a001107; http://dx.doi.org/10.1101/cshperspect.a001107; PMID: 20182618
   PubMed Web of Science ®Google Scholar
• Shi ST, Yang GY, Wang LD, Xue Z, Feng B, Ding W, et al. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999; 20:591 - 7; http://dx.doi.org/10.1093/carcin/20.4.591; PMID: 10223186
   PubMed Web of Science ®Google Scholar
• Yasuda M, Kuwano H, Watanabe M, Toh Y, Ohno S, Sugimachi K. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Br J Cancer 2000; 83:1033 - 8; http://dx.doi.org/10.1054/bjoc.2000.1443; PMID: 10993651
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hamza MS, Leong HS, Lim CB, Pan YF, Cheung E, et al. Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells. Oncogene 2008; 27:1 - 8; http://dx.doi.org/10.1038/sj.onc.1210625; PMID: 17603560
   PubMed Web of Science ®Google Scholar
• Benjamin CL, Ananthaswamy HN. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2007; 224:241 - 8; http://dx.doi.org/10.1016/j.taap.2006.12.006; PMID: 17270229
   PubMed Web of Science ®Google Scholar
• McConnell BB, Yang VW. Mammalian Krüppel-like factors in health and diseases. Physiol Rev 2010; 90:1337 - 81; http://dx.doi.org/10.1152/physrev.00058.2009; PMID: 20959618
   PubMed Web of Science ®Google Scholar
• Geiman DE, Ton-That H, Johnson JM, Yang VW. Transactivation and growth suppression by the gut-enriched Krüppel-like factor (Krüppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res 2000; 28:1106 - 13; http://dx.doi.org/10.1093/nar/28.5.1106; PMID: 10666450
   PubMed Web of Science ®Google Scholar
• Zhang JS, Moncrieffe MC, Kaczynski J, Ellenrieder V, Prendergast FG, Urrutia R. A conserved α-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol Cell Biol 2001; 21:5041 - 9; http://dx.doi.org/10.1128/MCB.21.15.5041-5049.2001; PMID: 11438660
   PubMed Web of Science ®Google Scholar
• Love IM, Sekaric P, Shi D, Grossman SR, Androphy EJ. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle 2012; 11:2458 - 66; http://dx.doi.org/10.4161/cc.20864; PMID: 22713239
   PubMed Web of Science ®Google Scholar
• Matsumura T, Suzuki T, Aizawa K, Munemasa Y, Muto S, Horikoshi M, et al. The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Krüppel-like factor 5 through direct interaction. J Biol Chem 2005; 280:12123 - 9; http://dx.doi.org/10.1074/jbc.M410578200; PMID: 15668237
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Suzuki T, Muto S, Aizawa K, Kimura A, Mizuno Y, et al. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol Cell Biol 2003; 23:8528 - 41; http://dx.doi.org/10.1128/MCB.23.23.8528-8541.2003; PMID: 14612398
   PubMed Web of Science ®Google Scholar
• Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997; 90:595 - 606; http://dx.doi.org/10.1016/S0092-8674(00)80521-8; PMID: 9288740
   PubMed Web of Science ®Google Scholar
• Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011; 13:317 - 23; http://dx.doi.org/10.1038/ncb2173; PMID: 21336307
   PubMed Web of Science ®Google Scholar
• Pinho AV, Rooman I, Real FX. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle 2011; 10:1312 - 21; http://dx.doi.org/10.4161/cc.10.8.15363; PMID: 21490434
   PubMed Web of Science ®Google Scholar
• Chen C, Bhalala HV, Qiao H, Dong JT. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 2002; 21:6567 - 72; http://dx.doi.org/10.1038/sj.onc.1205817; PMID: 12242654
   PubMed Web of Science ®Google Scholar
• Chen C, Bhalala HV, Vessella RL, Dong JT. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 2003; 55:81 - 8; http://dx.doi.org/10.1002/pros.10205; PMID: 12661032
   PubMed Web of Science ®Google Scholar
• Nandan MO, McConnell BB, Ghaleb AM, Bialkowska AB, Sheng H, Shao J, et al. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 2008; 134:120 - 30; http://dx.doi.org/10.1053/j.gastro.2007.10.023; PMID: 18054006
   PubMed Web of Science ®Google Scholar
• McConnell BB, Bialkowska AB, Nandan MO, Ghaleb AM, Gordon FJ, Yang VW. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res 2009; 69:4125 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-08-4402; PMID: 19435907
   PubMed Web of Science ®Google Scholar
• Kim SH, Nakagawa H, Navaraj A, Naomoto Y, Klein-Szanto AJ, Rustgi AK, et al. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras. Cancer Res 2006; 66:10415 - 24; http://dx.doi.org/10.1158/0008-5472.CAN-06-2104; PMID: 17079462
   PubMed Web of Science ®Google Scholar
• Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, et al. Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res 2007; 67:7996 - 8001; http://dx.doi.org/10.1158/0008-5472.CAN-07-2064; PMID: 17804709
   PubMed Web of Science ®Google Scholar
• Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics 2008; Chapter 2:Unit 2 6.
   Google Scholar